Vascular Graft Solutions Wins FDA approval to Market the VIOLA(TM) Clampless Proximal Anastomosis System for CABG

TEL AVIV, Israel, March 1, 2021 -- (Healthcare Sales & Marketing Network) -- Vascular Grafts Solutions (VGS) Ltd. announced today receipt of marketing clearance from the Food and Drug Administration (FDA) for the VIOLA, a new device for clampless proxima... Devices, Cardiology, Surgery, FDA Vascular Graft Solutions, VIOLA , clampless, anastomosis, CABG

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2046695

Source: HSMN NewsFeed - March 1, 2021 Category: Pharmaceuticals Source Type: news